CogniScent
Berlin, Germany
We develop a novel, non invasive, software-based test for early detection of Alzheimer's and Parkinson's: using machine learning, we predict a personal risk score based on early risk factors and symptoms, where smell disorders play a key role.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- www.cogniscent.io
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of CogniScent?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now